MassMutual Private Wealth & Trust’s CorMedix CRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.11K Sell
534
-96
-15% -$769 ﹤0.01% 1684
2026
Q2
$4.95K Sell
630
-35
-5% -$277 ﹤0.01% 1687
2026
Q1
$4.51K Buy
665
+249
+60% +$1.84K ﹤0.01% 1719
2025
Q4
$4.84K Sell
416
-84
-17% -$929 ﹤0.01% 1685
2025
Q3
$5.82K Buy
500
+212
+74% +$2.56K ﹤0.01% 1610
2025
Q2
$3.55K Hold
288
– – ﹤0.01% 1764
2025
Q1
$1.77K Buy
+288
New +$2.98K ﹤0.01% 1954
2023
Q4
– Sell
-250
Closed -$925 – 1977
2023
Q3
$925 Buy
+250
New +$994 ﹤0.01% 1711

Other funds holding CRMD

MassMutual Private Wealth & Trust's CRMD Position: Q3 2026 in Review

MassMutual Private Wealth & Trust reduced its CorMedix (CRMD) stake by 15% in Q3 2026, selling an estimated $769 and leaving 534 shares worth $4.11K. The position accounts for ﹤0.01% of the portfolio, ranked #1684.

MassMutual Private Wealth & Trust first reported a position in CRMD in Q3 2023 and has held it in 8 quarters since. The position peaked at $5.82K in Q3 2025. 6 funds tracked by Wall St. Rank hold CRMD as of Q3 2026.

  • MassMutual Private Wealth & Trust held 534 shares of CorMedix worth $4.11K as of Q3 2026.
  • MassMutual Private Wealth & Trust sold 96 CorMedix shares in Q3 2026, an estimated $769.
  • CorMedix made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q3 2026, its #1684 holding.
  • MassMutual Private Wealth & Trust first reported a position in CorMedix in Q3 2023 and has held it in 8 quarters since.
  • MassMutual Private Wealth & Trust's CorMedix position peaked at $5.82K in Q3 2025.
  • 6 funds tracked by Wall St. Rank held CorMedix as of Q3 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2026, filed 5 Oct 2026.